The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations

Bertilsson L Carrillo JA Dahl ML , et al. (1994) Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 38: 471–473.

Blum A Mauruschat W (1972) Temperaturanstiege und Bluteiweiβveränderungen unter der Therapie mit Neuroleptika-unter besonderer Berücksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin. Pharmacopsychiatry 5: 155–169.

Cohen D Bogers JP van Dijk D , et al. (2012) Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry 73: 1307–1312.

Crilly J (2007) The history of clozapine and its emergence in the US market: A review and analysis. Hist Psychiatry 18: 39–60.

De Las Cuevas C Sanz EJ Ruan CJ , et al. (2022a) Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: Focus on reports from various countries. Rev Psiquiatr Salud Ment (Engl Ed). Epub ahead of print 21 July 2021. DOI: 10.1016/j.rpsm.2021.07.004.

De Las Cuevas C Sanz EJ Rohde C , et al. (2022b) Association between myocarditis and antipsychotics other than clozapine: A systematic literature review and a pharmacovigilance study using VigiBase. Expert Rev Clin Pharmacol 15: 65–78.

de Leon J (2022) Precision psychiatry: The complexity of personalizing antipsychotic dosing. Eur Neuropsychopharmacol 58: 80–85.

de Leon J Ruan CJ Schoretsanitis G , et al. (2020a) A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom 89: 200–214.

de Leon J Sanz EJ De Las Cuevas C (2020b) Data from the World Health Organization’s pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions. Schizophr Bull 46: 1–3.

de Leon J Schoretsanitis G Kane JM , et al. (2020c) Using therapeutic drug monitoring to personalize clozapine dosing in Asians. Asia Pac Psychiatry 12: e12384.

de Leon J Schoretsanitis G Smith RL , et al. (2022) An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry 55: 73–86.

Devarajan S Kutcher SP Dursun SM (2000) Clozapine and sudden death. Lancet 355: 841.

Diaz FJ Josiassen RC de Leon J (2018) The effect of body weight changes on total plasma clozapine concentrations determined by applying a statistical model to the data from a double-blind trial. J Clin Psychopharmacol 38: 442–446.

Helmchen H (1989) Clinical experience with clozapine in Germany. Psychopharmacology (Berl) 99 Suppl: S80–S83.

Higgins JM San C Lagnado G , et al. (2019) Incidence and management of clozapine-induced myocarditis in a large tertiary hospital. Can J Psychiatry 64: 561–567.

Idänpään-Heikkilä J Alhava E Olkinuora M , et al. (1975) Letter: Clozapine and agranulocytosis. Lancet 2: 611.

Jerling M Lindström L Bondesson U , et al. (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 16: 368–374.

Kilian JG Kerr K Lawrence C , et al. (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet 354:1841–1845.

Koenig M McCollum B Spivey JK , et al. (2022) Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases. Neuropsychopharmacol Hung 24: 29–41

McGrane I Spina E Hiemke C , et al. (2022). Pharmacokinetic drug interactions with oral haloperidol in adults: dose correction factors from a combined weighted analysis. Expert Opin Drug Metab Toxicol 18: 135–149.

Moore TJ Cohen MR Furberg CD (2007) Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 167: 1752–1759.

Naber D Leppig M Grohmann R , et al. (1989) Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia: A retrospective study of 387 patients. Psychopharmacology (Berl) 99 Suppl: S73–S76.

Netherlands Clozapine Collaboration Group (2013) Guideline for the use of clozapine. Available at: http://www.clozapinepluswerkgroep.nl/wp-content/uploads/2013/07/Guideline-for-the-use-of-Clozapine-2013.pdf (accessed 20 May 2022).

Rohde C Polcwiartek C Kragholm K , et al. (2018) Adverse cardiac events in out-patients initiating clozapine treatment: A nationwide register-based study. Acta Psychiatr Scand 137: 47–53.

Ronaldson KJ Fitzgerald PB McNeil JJ (2015) Clozapine-induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatr Scand 132: 231–240.

Ronaldson KJ Fitzgerald PB Taylor AJ , et al. (2012) Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A case-control study. Schizophr Res 141: 173–178.

Ruan CJ Zang YN Wang CY , et al. (2019) Clozapine metabolism in East Asians and Caucasians: A pilot exploration of the prevalence of poor metabolizers and a systematic review. J Clin Psychopharmacol 39: 135–144.

Sandarsh S Bishnoi RJ Shashank RB , et al. (2021) Monitoring for myocarditis during treatment initiation with clozapine. Acta Psychiatr Scand 144: 194–200.

Schoretsanitis G Ruan CJ Rohde C , et al. (2021) An update on the complex relationship between clozapine and pneumonia. Expert Rev Clin Pharmacol 14: 145–149.

Simpson GM Varga E (1974) Clozapine: A new antipsychotic agent. Curr Ther Res Clin Exp 116: 679–686.

Taylor D Vallianatou K Whiskey E , et al. (2022). Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis. NPJ Schizophr 8(1): 21.

Tsukahara M So R Yada Y , et al. (2021) Clinical utility and safety of slower-than-recommended titration of clozapine for treatment-resistant schizophrenia: A retrospective cohort study. Psychiatr Q 92: 703–713.